Skip to main content
Premium Trial:

Request an Annual Quote

William Welch

Trovagene has appointed William Welch as CEO, effective immediately, and has also annouced that Matthew Posard, the Company's Chief Commercial Officer, has left the firm.

Welch served previously as president and CEO of Sequenom where he initially began his career as senior vice president. Prior to joining Sequenom, Welch was a consultant to various molecular diagnostic companies in the personalized medicine sector. Before that, he held leadership and management roles at Monogram Biosciences, La Jolla Pharmaceuticals, Dade Behring MicroScan, and Abbott Laboratories.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.